Dermapharm Holding SE (DMPG)

Xetra
Currency in EUR
Disclaimer
39.48
-0.32
(-0.80%)
Closed
Day's Range
39.20
39.90
52 wk Range
34.30
49.48
Volume
23,699
Bid/Ask
39.32 / 39.48
Prev. Close
39.8
Open
39.76
Day's Range
39.2-39.9
52 wk Range
34.3-49.48
Volume
23,699
Average Volume (3m)
18,402
1-Year Change
6.47%
Shares Outstanding
53,840,000
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
56.75
Upside +43.74%

People Also Watch

52.05
STM1
+1.66%
38.20
VRLA
+0.53%
142.700
HYQGn
-1.18%
215.000
AOFG
+0.47%
58.550
TLXGn
-1.26%
How do you feel today about DMPG?
Vote to see community's results!
or

Dermapharm Holding SE Company Profile

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription healthcare products, herbal extracts, and other pharmaceutical products. It offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. The company also provides medical devices under the bite away and Herpotherm names. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.

Employees
3404
Market
Germany

Income Statement